Motilal Oswal Sees Sun Pharma Shares Reaching Rs 2025
Sun Pharma's Proposed Acquisition of Organon to Boost Portfolio and Global Reach
Sun Pharma (SUNP) is poised to experience significant growth with its proposed acquisition of New Jersey-based Organon. The USD12 billion all-cash acquisition is expected to expand SUNP's innovative medicines portfolio by adding a women's healthcare segment, boost its biosimilar offerings, and significantly expand its commercial footprint across 140+ countries.
The transaction will enhance SUNP's global positioning and portfolio diversification, with increased presence in women's health, innovative medicines, and biosimilars. It will also strengthen SUNP's scale across key international markets, including the US, EU, China, Canada, and Brazil.
Key Benefits of the Acquisition
Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data
| Category | Current Status | Post-Acquisition |
|---|---|---|
| Portfolio Expansion | SUNP's innovative medicines portfolio is currently underdeveloped | SUNP will add a women's healthcare segment and boost biosimilar offerings |
| Geographical Reach | SUNP operates in approximately 140 countries | SUNP will expand its commercial footprint across 140+ countries |
The acquisition is expected to provide several advantages for SUNP, including portfolio expansion, healthcare professional connect, and geographical reach. With a valuation of approximately 32x 12 months forward earnings, the transaction is expected to be a significant growth driver for the company.
We value Sun Pharma at INR2,025 and maintain a BUY recommendation on the stock.
Investor Takeaway
Investors should consider buying Sun Pharma shares due to its proposed acquisition of Organon.
More in Market
Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data
US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline
Indian Stocks to Watch: BHEL, Agarwal Industrial, JBM Auto, Rajesh Exports, Indian Energy Exchange, Lenskart Solutions in Market Focus on June 4.
